secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2023-04-17T23:59:59+00:00
Accession:  0001104659-23-046197
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics CEO Osvaldo Flores steps down; Gregory Russotti named interim CEO, Michael Diem appointed CFO
--------------------------------------------------------------------------------

- Osvaldo Flores stepped down as President, CEO, and Board member effective April 11, 2023; no disagreement with the company.
- Board appointed Gregory Russotti (previously CTO) as Interim President and CEO; salary raised to $614,092.50.
- Russotti received a one-time option grant of 318,750 shares at $3.16/share, vesting over 4 years.
- Michael Diem, previously Chief Business Officer, promoted to CFO; compensation for new role TBD.
- Board reduced from 8 to 7 members following Flores' departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465923046197/0001104659-23-046197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465923046197/tm239540d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-046197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer